Skip to main content
Screener/Healthcare/Biotechnology

RGNX — REGENXBIO Inc.

NASDAQ
$6.97-0.10 (-1.41%)
Small CapUnder $10Healthcare
$5.46
$16.19
$6.58
$7.13
EPS (TTM)$-5.60
P/E Ratio-2.32
Dividend Yield—
Market Cap$365.5M
Volume648K
Prev Close$7.07
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$6.4M-$90.1M$-1.72-73.2%-1408.6%
Q4 '25$30.3M-$67.1M$-1.3080.5%-221.3%
Q3 '25$29.7M-$61.9M$-1.20-107.9%-208.3%
Q2 '25$21.4M-$70.9M$-1.3857.3%-331.8%
Q1 '25$89.0M$6.1M$0.1296.1%6.8%
Q4 '24$21.2M-$51.2M$-1.0170.2%-241.3%
Q3 '24$24.2M-$59.6M$-1.1748.8%-246.3%
Q2 '24$22.3M-$53.0M$-1.0534.4%-237.7%
Get Your Daily Market Recap